Genetic variation plays a key role in how a patient responds to a drug or medical products, yet clinical trials for new drugs and medicines often lack diversity and minority-equity.

Chadwick Boseman's death has made many of us wonder if he had a better chance of surviving colon cancer if there was more information on how people of color respond to current colon cancer treatment options.

In conversation with Alekhya Pochiraju, a biomarker operations manager who provides deeper insights into the why and how of the need of diversity in clinical trials.

Link to daily Gratitude Affirmations: https://rashimmogha.com/2018/10/29/positive-affirmations-they-work/.

Please consider supporting this podcast so that we can empower women globally: anchor.fm/rashim-mogha/support .

Link to eWOW Virtual Incubator Program: https://www.ewowglobal.com/events/ . Email your feedback at: empoweredWOW@gmail.com

eWOW #12: Building Resilience

eWOW ℠ - empowered Women Of the World ℠ By eWOWFeb 04, 2019